Cogniz Tablet 500 mg

Cogniz Tablet 500 mg Uses, Dosage, Side Effects, Food Interaction and all others data.

Cogniz Tablet 500 mg
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Cogniz Tablet 500 mg
Generic	Citicoline Sodium
Weight	500 mg
Type	Tablet
Therapeutic Class	CNS stimulant drugs
Manufacturer	UniMed UniHealth Pharmaceuticals Ltd.
Available Country	Bangladesh
Last Updated:	October 19, 2023 at 6:27 am

Uses

Cogniz Tablet 500 mg is indicated in- Cerebrovascular disease e.g. ischemia due to stroke, where Citicoline accelerates the recovery of consciousness & overcoming motor deficit. Treatment within the first 24 hours after onset in patients with moderate to severe stroke increases the probability of complete recovery in 3 months. ... Read more

Dosage

Cogniz Tablet 500 mg dosage

Oral: Immediate treatment of stroke due to a clot (ischemic stroke): 500-2000 mg of Citicoline per day, start within 24 hours of stroke. For decline in thinking skills due to stroke: 1000-2000 mg of Citicoline per day. Chronic cerebrovascular disease: 1000 mg daily in divided dose with or between meals for ongoing disease of the blood vessels that serve the brain. Injection: 1 to 2 injections daily. Adjust dosage according to the severity. Can be administered through intramuscular (IM), or intravenous (IV) [ 3 to 5 minutes] route. Geriatric use: No dosage adjustment is required & the usual dose can be administered.

Side Effects

Occasionally Citicoline may exert stimulating action of the parasympathetic system as well as a fleeting & discrete hypotensive effect.

Precaution

Citicoline is known to cause increased dizziness or drowsiness. So, it is strongly recommended that patients do not operate any type of machinery throughout the course of treatment. Citicoline may cause hypotension and in case necessary the hypotensive effect can be treated with corticosteroids or sympathomimetic. In case of persistent intracranial hemorrhage, the very slow administration [30 drops/minutes] is recommended; the administration of larger doses could provoke an increase of the cerebral blood flow. The patient should not consume alcohol while taking Citicoline.

Interaction

Citicoline may enhance the effects of levodopa, carbidopa & entacapone. Citicoline must not be administered with products containing meclophenoxate.

Pregnancy & Breastfeeding use

There are no adequate & well controlled studies of Citicoline during pregnancy & lactation. Citicoline should be used during pregnancy & lactation only if the potential benefits justify the potential risks.